Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19
Companies have set up a Joint Task Force
15-Apr-2020 -
Sanofi and GSK announce that they have signed a letter of intent to develop an adjuvanted vaccine for COVID-19, using innovative technology from both companies, to help address the ongoing pandemic.
Sanofi will contribute its S-protein COVID-19 antigen, which is based on recombinant DNA ...
adjuvants
coronaviruses
Covid-19
+2